The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
Conditions: Obesity; Metabolic Syndrome Interventions: Drug: Empagliflozin 25 MG; Drug: Placebo Sponsor: Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials